Page 141 - Recognizing axial spondyloarthritis - Janneke de Winter

REFERENCES
1. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645–2654.
2. Seo MR, Baek HL, Yoon HH, Ryu HJ, Choi HJ, Baek HJ, et al. Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol 2015;34:1397–1405.
3. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960–977.
4. Bos WH, Dijkmans BAC, Boers M, Stadt RJ Van De, Schaardenburg D Van. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: A randomised trial. Ann Rheum Dis 2010;69:571–574.
5. Gerlag D, Safy M, Maijer KI, Tas SW, Starmans-kool M, Tubergen A van, et al. A single infusion of rutiximab delays the onset of arthritis in subjects at high risk for developing RA. ACR Annu Meet 2016;68:54–55.
6. Rech J, Schett G. Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia (ARIAA). ClinicalTrials.gov 2014.
7. Turina MC, Winter JJ de, Paramarta
JE, Gamala M, Yeremenko N, Nabibux MN, et al. Clinical and imaging signs of spondyloarthritis in first-degree relatives of HLA-B27 positive ankylosing spondylitis patients: The pre-spondyloarthritis (Pre-SpA) cohort. Arthritis Rheumatol (Hoboken, NJ) 2016;11:300–308.
8. Berg R van den, Hooge M de, Gaalen F van, Reijnierse M, Huizinga T, Heijde D van der. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford)2013;52:1492–9.
9. Finckh A, Escher M, Liang MH, Bansback N. Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences. Curr Rheumatol Rep 2016;18.
10. Port E, Montgomery L, Heerdt A, Borgen P. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 2001;8:580–585.
11. Bo NJ, Ejg JD, Dorte G-H, Lind BBM, Veldt LP. Determinants for acceptance of preventive treatment against heart disease – a web-based population survey. BMC Public Health 2014;14:783.
12. Marshall D, Bridges J, Hauber B, Cameron R, Donnalley L, Fyie K, et al. No Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008. Patient 2010;1:249–56.
PREVENTIVE MEDICATION IN AXIAL SPA
139
EIGHT